LYMPHEDEMA DURATION AS A PREDICTIVE FACTOR OF EFFICACY OF COMPLETE DECONGESTIVE THERAPY
Lymphology · 2022
DOI: 10.2458/lymph.4788 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lymphology, 2022. Verfasst von E. Michopoulos und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Lymphedema is a common condition with global impact and a multitude of complications, however, only a few professionals specialize in its management. A retrospective analysis of 105 subjects with unilateral lymphedema upper or lower limb was performed to investigate whether the duration of lymphedema constitutes an important factor associated with the efficacy of complete decongestive therapy (CDT). Subjects were classified into two groups according to the duration of lymphedema, prior to CDT: group A (≤1 year) and group B (>1 year). Both groups were treated daily according to the same CDT protocol for four weeks. The CDT efficacy was determined based on the percent reduction of excess volume (PREV) measurements. Lymphedema was significantly reduced in both groups of subjects, but significantly more in group A (p
Zitieren
APA
Michopoulos, E., Papathanasiou, G., Krousaniotaki, K., Vathiotis, I., Troupis, T., & Dimakakos, E. (2022). LYMPHEDEMA DURATION AS A PREDICTIVE FACTOR OF EFFICACY OF COMPLETE DECONGESTIVE THERAPY. Lymphology. https://doi.org/10.2458/lymph.4788
Vancouver
Michopoulos E, Papathanasiou G, Krousaniotaki K, Vathiotis I, Troupis T, Dimakakos E. LYMPHEDEMA DURATION AS A PREDICTIVE FACTOR OF EFFICACY OF COMPLETE DECONGESTIVE THERAPY. Lymphology. 2022. doi:10.2458/lymph.4788
BibTeX
@article{Michopoulos2022,
author = {Michopoulos, E. and Papathanasiou, G. and Krousaniotaki, K. and Vathiotis, I. and Troupis, T. and Dimakakos, E.},
title = {LYMPHEDEMA DURATION AS A PREDICTIVE FACTOR OF EFFICACY OF COMPLETE DECONGESTIVE THERAPY},
journal = {Lymphology},
year = {2022},
doi = {10.2458/lymph.4788}
}
EUVIMED